Shining some light on the obscure proteome: Chemoproteomics draw the target landscape of HDAC drugs
Histone deacetylase (HDAC) inhibitors are a class of drugs used in oncology. An international research team involving scientists at the Technical University of Munich (TUM), Cornell University in Ithaca (USA), the German Cancer Research…